MCID: STM006
MIFTS: 50

Stomach Disease

Categories: Gastrointestinal diseases

Aliases & Classifications for Stomach Disease

MalaCards integrated aliases for Stomach Disease:

Name: Stomach Disease 12 15
Stomach Diseases 44 73
Gastropathy 12 55
Stomach Disorders 43
Stomach Disorder 12
Gastric Disorder 55
Gastric Disease 12

Classifications:



External Ids:

Disease Ontology 12 DOID:76
MeSH 44 D013272
NCIt 50 C26886
SNOMED-CT 68 29384001
UMLS 73 C0038354

Summaries for Stomach Disease

MedlinePlus : 43 Your stomach is an organ between your esophagus and small intestine. It is where digestion of protein begins. The stomach has three tasks. It stores swallowed food. It mixes the food with stomach acids. Then it sends the mixture on to the small intestine. Most people have a problem with their stomach at one time or another. Indigestion and heartburn are common problems. You can relieve some stomach problems with over-the-counter medicines and lifestyle changes, such as avoiding fatty foods or eating more slowly. Other problems like peptic ulcers or GERD require medical attention. You should see a doctor if you have any of the following: Blood when you have a bowel movement Severe abdominal pain Heartburn not relieved by antacids Unintended weight loss Ongoing vomiting or diarrhea NIH: National Institute of Diabetes and Digestive and Kidney Diseases

MalaCards based summary : Stomach Disease, also known as stomach diseases, is related to functional gastric disease and gastritis, and has symptoms including nausea and vomiting, constipation and abdominal pain. An important gene associated with Stomach Disease is PTGS2 (Prostaglandin-Endoperoxide Synthase 2), and among its related pathways/superpathways are WNT Signaling and Colorectal Cancer Metastasis. The drugs Racepinephrine and Epinephrine have been mentioned in the context of this disorder. Affiliated tissues include kidney, small intestine and lung, and related phenotypes are Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection and digestive/alimentary

Disease Ontology : 12 A gastrointestinal system disease that is located in the stomach.

Wikipedia : 76 Stomach diseases (or gastropathy) include gastritis, gastroparesis, diarrhea, Crohn''s disease and... more...

Related Diseases for Stomach Disease

Diseases related to Stomach Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 187)
# Related Disease Score Top Affiliating Genes
1 functional gastric disease 33.5 ATP12A ATP4A GHRL HRH2 TRPV1
2 gastritis 31.5 AREG GAST GHRL HRH2 PTGS2 S100A8
3 gastric antral vascular ectasia 30.9 ATP12A ATP4A
4 bile reflux 30.5 ATP12A ATP4A PTGS2
5 peptic ulcer disease 30.4 ATP4A GAST GHRL HRH2 PTGS2 S100A8
6 granulomatous gastritis 30.2 ATP12A ATP4A GAST
7 duodenitis 30.2 ATP12A ATP4A GAST
8 active peptic ulcer disease 30.2 ATP12A ATP4A HRH2 PTGS1 PTGS2
9 rheumatic disease 30.1 PTGS1 PTGS2 TLR9
10 esophageal cancer 30.0 CDH1 CEACAM5 ERBB2 PTGS2 TP53
11 gastric adenocarcinoma 30.0 CDH1 CEACAM5 ERBB2 GAST PTGS2 S100A8
12 barrett's adenocarcinoma 29.8 ERBB2 PTGS2 TP53
13 adenocarcinoma 29.8 CDH1 ERBB2 PTGS2 TP53
14 duodenal ulcer 29.8 GAST HRH2 S100A8
15 non-hypoproteinemic hypertrophic gastropathy 12.1
16 gastritis, familial giant hypertrophic 11.9
17 photoallergic dermatitis 10.4 ATP12A ATP4A PTGS2
18 fungal esophagitis 10.4 ATP12A ATP4A
19 aspiration pneumonitis 10.4 ATP12A ATP4A HRH2
20 diclofenac allergy 10.4 ATP12A ATP4A
21 gastroduodenal crohn's disease 10.4 ATP12A ATP4A
22 peptic esophagitis 10.4 ATP12A ATP4A HRH2
23 laryngitis 10.4 ATP12A ATP4A HRH2
24 chronic laryngitis 10.4 ATP12A ATP4A HRH2
25 pancreatic steatorrhea 10.4 ATP12A ATP4A GHRL
26 morphine dependence 10.4 PTGS1 PTGS2 TRPV1
27 neonatal candidiasis 10.4 ATP12A ATP4A
28 gastrointestinal neuroendocrine benign tumor 10.4 ATP12A ATP4A GAST
29 aspiration pneumonia 10.4 ATP12A ATP4A TRPV1
30 gastric neuroendocrine neoplasm 10.4 ATP12A ATP4A GAST
31 microinvasive gastric cancer 10.4 ATP12A ATP4A CDH1
32 breast cystic hypersecretory carcinoma 10.4 CDH1 ERBB2
33 paine syndrome 10.4 ATP12A ATP4A TRPV1
34 squamous papillomatosis 10.4 ATP12A ATP4A
35 gastric papillary adenocarcinoma 10.4 ERBB2 TP53
36 gastric lymphoma 10.4 ATP12A ATP4A TP53
37 uterine corpus serous adenocarcinoma 10.3 ERBB2 TP53 TUBB3
38 adenomyosis 10.3 CDH1 PTGS2 TRPV1
39 aspirin resistance 10.3 PTGS1 PTGS2
40 blind loop syndrome 10.3 ATP12A ATP4A GHRL HRH2
41 intracystic papillary adenoma 10.3 CEACAM5 ERBB2
42 gallbladder squamous cell carcinoma 10.3 CEACAM5 ERBB2
43 uterine corpus cancer 10.3 ERBB2 TP53 TUBB3
44 esophageal adenosquamous carcinoma 10.3 CDH1 CEACAM5
45 tonsil cancer 10.3 CDH1 ERBB2 TP53
46 colonic benign neoplasm 10.3 AREG CEACAM5 PTGS2
47 cerebral convexity meningioma 10.3 CDH1 TP53
48 pre-malignant neoplasm 10.3 CDH1 ERBB2 TP53
49 cervical adenocarcinoma 10.3 ERBB2 PTGS2 TP53
50 tongue disease 10.3 CDH1 TLR9 TP53

Graphical network of the top 20 diseases related to Stomach Disease:



Diseases related to Stomach Disease

Symptoms & Phenotypes for Stomach Disease

UMLS symptoms related to Stomach Disease:


nausea and vomiting, constipation, abdominal pain, diarrhea, icterus, signs and symptoms, digestive, dyspepsia, heartburn, gastrointestinal gas, stomach ache

GenomeRNAi Phenotypes related to Stomach Disease according to GeneCards Suite gene sharing:

26
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased JFH-1 genotype 2a Hepatitis C virus (HCV) infection GR00233-A-1 9.02 CDH1 DDX21 ERBB2 GKN2 TUBB3

MGI Mouse Phenotypes related to Stomach Disease:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 digestive/alimentary MP:0005381 10.22 AREG ATP12A ATP4A CDH1 ERBB2 GAST
2 homeostasis/metabolism MP:0005376 10.2 AREG ATP12A ATP4A CDH1 ERBB2 GAST
3 endocrine/exocrine gland MP:0005379 10.11 AREG ATP4A CDH1 ERBB2 GAST GHRL
4 immune system MP:0005387 10 AREG ATP4A CDH1 GAST GKN2 HDC
5 integument MP:0010771 9.76 AREG CDH1 ERBB2 HDC PTGS1 PTGS2
6 mortality/aging MP:0010768 9.73 AREG ATP4A CDH1 DDX21 ERBB2 GAST
7 neoplasm MP:0002006 9.28 ATP4A CDH1 ERBB2 GAST GKN2 PTGS1

Drugs & Therapeutics for Stomach Disease

Drugs for Stomach Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 681)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Racepinephrine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 329-65-7 838
2
Epinephrine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 51-43-4 5816
3
Domperidone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 57808-66-9 3151
4
Dopamine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 51-61-6, 62-31-7 681
5
Ursodeoxycholic acid Approved, Investigational Phase 4 128-13-2 31401
6
Histamine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 51-45-6, 75614-87-8 774
7
Mianserin Approved, Investigational Phase 4 24219-97-4 4184
8
Mirtazapine Approved Phase 4 61337-67-5, 85650-52-8 4205
9
Esomeprazole Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 161796-78-7, 119141-88-7 4594 9579578
10
Lansoprazole Approved, Investigational Phase 4,Phase 3,Not Applicable 103577-45-3 3883
11
Dexlansoprazole Approved, Investigational Phase 4,Phase 3,Not Applicable 103577-45-3, 138530-94-6 9578005
12
Amoxicillin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 26787-78-0 33613
13
Clarithromycin Approved Phase 4,Phase 3,Phase 2,Not Applicable 81103-11-9 84029
14
Rabeprazole Approved, Investigational Phase 4,Phase 2,Phase 3,Not Applicable 117976-89-3 5029
15
Metronidazole Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 443-48-1 4173
16
Trimebutine Approved Phase 4 39133-31-8
17
Irinotecan Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 100286-90-6, 97682-44-5 60838
18
Capecitabine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 154361-50-9 60953
19
Trastuzumab Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 180288-69-1 9903
20
Oxaliplatin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 61825-94-3 43805 6857599 5310940 9887054
21
Bevacizumab Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 216974-75-3
22
Iron Approved Phase 4,Phase 2,Phase 3 7439-89-6 23925
23 lanreotide Approved Phase 4,Phase 2,Phase 1 108736-35-2
24
Somatostatin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 51110-01-1, 38916-34-6 53481605
25
Pantoprazole Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 102625-70-7 4679
26
Ticlopidine Approved Phase 4,Phase 2,Not Applicable 55142-85-3 5472
27
Clopidogrel Approved Phase 4,Phase 2,Not Applicable 113665-84-2, 120202-66-6 60606
28
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 50-78-2 2244
29
Pravastatin Approved Phase 4 81093-37-0 54687
30
Propranolol Approved, Investigational Phase 4,Not Applicable 525-66-6 4946
31
Omeprazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 73590-58-6 4594
32
Famotidine Approved Phase 4,Phase 3,Not Applicable 76824-35-6 3325
33
Sucralfate Approved Phase 4,Not Applicable 54182-58-0 0
34
Tetracycline Approved, Vet_approved Phase 4,Phase 3,Not Applicable 60-54-8 5353990
35
Ofloxacin Approved Phase 4,Phase 3,Not Applicable 82419-36-1 4583
36
Levofloxacin Approved, Investigational Phase 4,Phase 3,Not Applicable 100986-85-4 149096
37
Simethicone Approved Phase 4,Phase 3,Phase 2 8050-81-5
38
Acetylcysteine Approved, Investigational Phase 4,Phase 2,Phase 3 616-91-1 12035
39
Fluorouracil Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 51-21-8 3385
40
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4,Phase 3,Not Applicable 437-38-7 3345
41
leucovorin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 58-05-9 6006 143
42
Levoleucovorin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 68538-85-2
43
Zinc Approved, Investigational Phase 4,Phase 2,Not Applicable 7440-66-6
44
Carvedilol Approved, Investigational Phase 4,Not Applicable 72956-09-3 2585
45
Wormwood Approved, Experimental Phase 4,Phase 2
46
Ethanol Approved Phase 4,Phase 2,Not Applicable 64-17-5 702
47
Hydroxocobalamin Approved Phase 4,Phase 2,Not Applicable 13422-51-0 11953898 44475014
48
Methylcobalamin Approved, Experimental, Investigational Phase 4,Phase 2,Not Applicable 13422-55-4
49
Amphotericin B Approved, Investigational Phase 4 1397-89-3 5280965 14956
50
Magnesium Sulfate Approved, Investigational, Vet_approved Phase 4,Phase 3 7487-88-9 24083

Interventional clinical trials:

(show top 50) (show all 2186)
# Name Status NCT ID Phase Drugs
1 Trial of Hemospray Plus Epinephrine Injection Versus Endoscopic Hemoclip Unknown status NCT02537353 Phase 4 Hemospray;Adrenaline
2 Outcome Study of Double Bare Stent for Malignant Gastric Outlet Obstruction Unknown status NCT02156505 Phase 4
3 Prucalopride Versus Placebo in Gastroparesis Unknown status NCT02510976 Phase 4 prucalopride;placebo
4 Effects and Mechanism of Mosapride Citrate on Diabetic Gastroparesis Unknown status NCT02264587 Phase 4 Mosapride;domperidone
5 Therapeutic Effect of Ursodeoxycholic Acid in Functional Dyspepsia Unknown status NCT03004118 Phase 4 Placebo Oral Tablet;Ursochol oral tablet
6 Mirtazapine Versus Placebo in Functional Dyspepsia Unknown status NCT01240096 Phase 4 Mirtazapine
7 Oral vs Intravenous and Proton Pump Inhibitor (PPI)for Peptic Ulcer Bleeding (PUB) Unknown status NCT01123031 Phase 4 lansoprazole;esomeprazole
8 Compare Efficacy of Gastric Acid Suppression by Oral and Intravenous Administration of Esomeprazole in Patients With Peptic Ulcer Unknown status NCT00471029 Phase 4 esomeprazole
9 Concomitant Therapy of H. Pylori Unknown status NCT01922765 Phase 4 amoxicillin, clarithromycin, metronidazole, rabeprazole
10 Trimebutine Maleate Combined With Rabeprazole in Patients With Grade A or B Reflux Esophagitis Whose Symptoms Refractory to Rabeprazole Unknown status NCT02986685 Phase 4 Trimebutine Maleate;rabeprazole
11 A Clinical Trial of Maintenance Treatment of Apatinib in Advanced Gastric Cancer Patients Have Completed Postoprative Adjuvant Chemotherapy Unknown status NCT02776527 Phase 4 Apatinib Mesylate Tablets
12 Treatment Effect Between Dexlansoprazole and Double-dose Lansoprazole in Obesity Patients With Reflux Esophagitis Unknown status NCT02759393 Phase 4 Dexlansoprazole;Lansoprazole
13 Effects of Ilaprazole on Ulcer Healing Rate and Prevention of Gastrointestinal Bleeding in the Patients Undergone ESD. Unknown status NCT02638584 Phase 4 Ilaprazole;Rabeprazole
14 Study of Apatinib Tablets in the Treatment of Advanced or Metastatic Gastric Cancer Unknown status NCT02426034 Phase 4 Apatinib
15 Irinotecan Plus Thalidomide in Second Line Advanced Gastric Cancer Unknown status NCT02401971 Phase 4 Thalidomide;CPT-11
16 Perioperative Chemotherapy With Herceptin For Potentially Resectable HER-2 Positive Gastric Cancer With Liver Metastasis Unknown status NCT02380131 Phase 4 Oxaliplatin plus Capecitabine;Herceptin
17 Preoperative Chemotherapy With Bevacizumab For Potentially Resectable Gastric Cancer With Liver Metastasis Unknown status NCT01962376 Phase 4 Oxaliplatin;Capecitabine;Oxaliplatin;Capecitabine;Bevacizumab
18 Iron Replacement in Oesophagogastric Neoplasia Unknown status NCT01927328 Phase 4 Iron isomaltoside 1000
19 Perioperative Application of Omega-3 Polyunsaturated Fatty Acids in Gastric Cancer Patients Unknown status NCT01910948 Phase 4 omega-3 polyunsaturated fatty acids
20 Treatment of the Dumping Syndrome With Lanreotide Autogel® Unknown status NCT00543179 Phase 4 Somatuline (Lanreotide Autogel®)
21 Parenteral Fish Oil in Major Laparoscopic Abdominal Surgery Unknown status NCT01819961 Phase 4 MCT/LCT and fish oil;MCT/LCT
22 Early Jejunostomy Nutrition Minimizes Time to Chemotherapy Unknown status NCT01766765 Phase 4
23 Does Early Re-administration of Aspirin/Clopidogrel Increase the Risk of Bleeding From Artificial Ulcer After EMR or ESD? Unknown status NCT01621451 Phase 4 aspirin and/or clopidogrel;aspirin and/or clopidogrel
24 Study to Evaluate the Efficacy of Pravastatin on Survival and Recurrence of Advanced Gastroesophageal Cancer Unknown status NCT01038154 Phase 4 Pravastatin
25 H. Pylori Eradication on Healing of Iatrogenic Gastric Ulcer by Endoscopic Mucosal Resection Unknown status NCT00926809 Phase 4 Lansoprazole (proton pump inhibitor), amoxicillin, clarythromycin;Lansoprazole (proton pump inhibitor), placebo
26 Helicobacter Pylori Empiric Treatment in Ulcer Bleeding Unknown status NCT00687336 Phase 4
27 Gastrectomy Plus Prophylactic Cholecystectomy in Gastric Cancer Surgery Unknown status NCT00757640 Phase 4
28 Randomized Double-Blind Clinical Trial of Rebamipide vs Esomeprazole in the Treatment of NSAID-induced Gastropathy Completed NCT00641004 Phase 4 Rebamipide and Esomeprazole
29 Effect of Early Oral Triple Viable Bifidobacterium Intestinal Flora in Preterm Completed NCT02060084 Phase 4 a control group;a probiotic-supplemented group
30 High Dose PPI Triple Therapy Versus Sequential Therapy for Helicobacter Pylori Eradication Completed NCT01888237 Phase 4 Double dose of PPI;sequence of drug use
31 Study on B-blockers to Prevent Decompensation of Cirrhosis With HTPortal Completed NCT01059396 Phase 4 propranolol;carvedilol;placebo
32 PROPRANOLOL PLUS LIGATION REDUCES RECURRENCE OF ESOPHAGEAL VARICES? Completed NCT01893541 Phase 4 PROPRANOLOL
33 Clinical Effect of Rebamipide on Chronic Gastritis Completed NCT02393430 Phase 4 Rebamipide
34 Efficacy and Safety of Eupasidin-s Tab.(EUPASIDIN-S) in Gastritis Patients Completed NCT02356679 Phase 4 Eupasidin-s Tab;Stillen Tab.
35 A Study to Evaluate the Efficacy and of Stillen Tab. and to Demonstrate the Non-inferiority of Stillen Tab. Completed NCT01817556 Phase 4 Stillen Tab.;Mucosta Tab.
36 The Pilot Study on Tailored Eradication Therapy According to Clarithromycin Resistance in H.Pylori Patients Completed NCT02648659 Phase 4 Ilaprazole;Amoxicillin;Clarithromycin;Metronidazole
37 To Evaluate the Efficacy and Safety of Vitamin B12 Contains Extract of Lamb's Stomach in Treatment of Chronic Atrophic Gastritis (CAG) Completed NCT01474044 Phase 4 Gastropylor Complex Capsules
38 Different Dose of Intravenous Omeprazole to Treat Bleeding Ulcer With Adherent Clot Completed NCT02536989 Phase 4 omeprazole;omeprazole
39 The Effect of Perioperative Intravenous Magnesium on Pain After Endoscopic Submucosal Dissection for Gastric Neoplasm: Prospective Randomized Double-blind Placebo Controlled Study Completed NCT02235246 Phase 4 Magnesium Sulfate;Normal saline
40 The Efficacy and Safety Study of Rikkunshito in Patients With Functional Dyspepsia Completed NCT02037776 Phase 4 Rikkunshito;Rikkunshito placebo
41 Fast-track Surgery for Perforated Peptic Ulcers Completed NCT01620671 Phase 4
42 Improving Complete Endoscopic Mucosal Resection (EMR) of Colorectal Neoplasia Completed NCT01471756 Phase 4
43 A Comparison of Two Therapeutic Strategies for the Treatment of Aspirin-associated Peptic Ulcers Completed NCT01353144 Phase 4 aspirin
44 Efficacy of Banhasasim-tang on Functional Dyspepsia Completed NCT00987805 Phase 4
45 Famotidine Compared With Pantoprazole to Prevent Recurrent Aspirin-Induced Peptic Ulcer/Erosion Completed NCT00843063 Phase 4 pantoprazole vs famotidine
46 The Dissemination of Consensus Recommendations on Upper Gastrointestinal Bleeding Completed NCT00840008 Phase 4
47 Effect of Naproxen, Aspirin, Celecoxib, or Clopidogrel on the Healing of Stomach and Intestinal Ulcers Completed NCT00778193 Phase 4 Naproxen;Aspirin;Celecoxib;Clopidogrel;Placebo
48 Ulcer Prevention Study in Post Gastric Bypass Patients Completed NCT00557349 Phase 4 Omeprazole;Famotidine
49 Importance of Cytokines in Peptic Ulcer Disease: Implications for Treatment Completed NCT00534443 Phase 4
50 Celebrex Low Dose ASA Study Examining the Incidence of Gastroduodenal Ulcers in a Healthy Population Completed NCT00137033 Phase 4 Celecoxib;Naproxen;ASA

Search NIH Clinical Center for Stomach Disease

Cochrane evidence based reviews: stomach diseases

Genetic Tests for Stomach Disease

Anatomical Context for Stomach Disease

MalaCards organs/tissues related to Stomach Disease:

41
Kidney, Small Intestine, Lung, Liver, Colon, Tongue, Pancreas

The Foundational Model of Anatomy Ontology organs/tissues related to Stomach Disease:

19
The Stomach

Publications for Stomach Disease

Articles related to Stomach Disease:

(show all 17)
# Title Authors Year
1
Levels of malondialdehyde in the gastric juice: Its association with Helicobacter pylori infection and stomach diseases. ( 29315971 )
2018
2
Alterations in Th17 and the Respective Cytokine Levels in Helicobacter pylori-Induced Stomach Diseases. ( 25908492 )
2015
3
The human gastric microbiota: Is it time to rethink the pathogenesis of stomach diseases? ( 26137299 )
2015
4
[Stomach disease and ghrelin]. ( 15506414 )
2004
5
Three-dimensional computer images of stomach diseases. ( 11869710 )
2002
6
A case-control study on risk factors of helicobacter pylori infection in out-patients with stomach diseases. ( 12410954 )
2002
7
Stomach diseases: MR evaluation using combined t2-weighted single-shot echo train spin-echo and gadolinium-enhanced spoiled gradient-echo sequences. ( 10581508 )
1999
8
A nucleolar RNA helicase recognized by autoimmune antibodies from a patient with watermelon stomach disease. ( 8614622 )
1996
9
Some aspects of gastric secretory tests in dogs for diagnostic purposes in two selected cases of stomach disease. ( 6860926 )
1983
10
The gastrocamera in the diagnosis of stomach disease. ( 5694513 )
1968
11
Chromatographic analysis of free amino acids of gastric juice in patients with cancer and other stomach diseases. ( 6063013 )
1967
12
Mortality from major stomach diseases: contrasting trends noted. ( 5971605 )
1966
13
Intrinsic-factor secretion in stomach diseases. ( 4158820 )
1965
14
GASTROSCOPY AND DIRECTED GASTROBIOPSY IN DIAGNOSING STOMACH CANCER AND SOME PRECANCEROUS STOMACH DISEASES. ( 14103901 )
1963
15
[New therapeutic possibilities in stomach diseases]. ( 13622177 )
1959
16
[A contribution to diagnosis, symptomatology and therapy of inflammatory stomach diseases with sucsan-azulene]. ( 13577777 )
1958
17
Some Results of Gastric Analysis in Stomach Disease, with Illustrative Cases. ( 30435831 )
1899

Variations for Stomach Disease

Expression for Stomach Disease

Search GEO for disease gene expression data for Stomach Disease.

Pathways for Stomach Disease

Pathways related to Stomach Disease according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.96 CDH1 GAST PTGS2 TP53
2 11.47 CDH1 PTGS2 TLR9 TP53
3 11.2 CDH1 ERBB2 TP53
4 10.5 PTGS1 PTGS2
5 9.5 ATP4A GAST HRH2

GO Terms for Stomach Disease

Cellular components related to Stomach Disease according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 membrane GO:0016020 9.83 AREG ATP12A ATP4A CDH1 CEACAM5 DDX21
2 basolateral plasma membrane GO:0016323 8.92 ATP12A CEACAM5 ERBB2 TLR9

Biological processes related to Stomach Disease according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 negative regulation of apoptotic process GO:0043066 9.77 CEACAM5 ERBB2 GHRL PTGS2 TP53
2 prostaglandin biosynthetic process GO:0001516 9.4 PTGS1 PTGS2
3 establishment or maintenance of transmembrane electrochemical gradient GO:0010248 9.32 ATP12A ATP4A
4 cellular potassium ion homeostasis GO:0030007 9.26 ATP12A ATP4A
5 sodium ion export across plasma membrane GO:0036376 9.16 ATP12A ATP4A
6 inflammatory response GO:0006954 9.02 PTGS1 PTGS2 S100A8 TLR9 TRPV1
7 cyclooxygenase pathway GO:0019371 8.96 PTGS1 PTGS2

Molecular functions related to Stomach Disease according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 sodium:potassium-exchanging ATPase activity GO:0005391 9.16 ATP12A ATP4A
2 potassium:proton exchanging ATPase activity GO:0008900 8.96 ATP12A ATP4A
3 prostaglandin-endoperoxide synthase activity GO:0004666 8.62 PTGS1 PTGS2

Sources for Stomach Disease

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....